Hereditas

Papers
(The H4-Index of Hereditas is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
A novel chromatin regulator-related immune checkpoint related gene prognostic signature and potential candidate drugs for endometrial cancer patients37
Prognostic value of LncRNA PSMA3-AS1 in prostate cancer and its potential regulatory mechanism29
miR-3913-3p promoted the progression of lung adenocarcinoma by regulating STX3 expression26
Cellular plasticity and heterogeneity underlying therapy resistance in 3D cervical cancer models22
Upregulation of CENPM is associated with poor clinical outcome and suppression of immune profile in clear cell renal cell carcinoma21
Serum LINC01127 serves as a diagnostic biomarker for sepsis and its predictive value for clinical outcomes21
Insulin-like growth factor binding protein 2: a core biomarker of left ventricular dysfunction in dilated cardiomyopathy18
Identification and validation of USP15 and CUL2 as ubiquitination related biomarker in chronic obstructive pulmonary disease18
NSUN2 restrains gastric cancer cell apoptosis and ferroptosis by promoting the m5C modification of EPYC17
Integrating bioinformatics analysis, machine learning, and experimental validation to identify pyroptosis-related genes in the diagnosis of sepsis combined with acute liver failure16
Prognostic value of Linc00662/miR-16-5p/FASN in cervical cancer and regulation of tumor progression16
Mediating Mendelian randomization in the proteome identified potential drug targets for obesity-related allergic asthma15
Extracellular vesicle-derived TP53BP1, CD34, and PBX1 from human peripheral blood serve as potential biomarkers for the assessment and prediction of vascular aging15
An 8-gene predicting survival model of hepatocellular carcinoma (HCC) related to pyroptosis and cuproptosis14
E2F1-driven EXOSC10 transcription promotes hepatocellular carcinoma growth and stemness: a potential therapeutic target14
0.050112009048462